Time to reconsider the role of ribavirin in Lassa fever

PLoS Negl Trop Dis. 2021 Jul 8;15(7):e0009522. doi: 10.1371/journal.pntd.0009522. eCollection 2021 Jul.

Abstract

Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Humans
  • Lassa Fever / drug therapy*
  • Lassa Fever / virology
  • Ribavirin / administration & dosage*

Substances

  • Antiviral Agents
  • Ribavirin